AEMD Aethlon Medical, Inc.
Aethlon Medical, Inc. (AEMD) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $1.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -9.4% since its last earnings release on November 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Aethlon Medical, Inc.
Aethlon Medical Inc manufactures medical devices to address unmet therapeutic needs in infectious disease, cancer and other life-threatening conditions. Its main product is the Aethlon Hemopurifier®.
Sector
Healthcare
Industry
Biotechnology
Charts powered in part by Lightweight Charts™ by TradingView.